vimarsana.com

Compaction Simulation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Genfit agrees to acquire biopharma firm Versantis for $109m

Genfit has signed an exclusivity agreement for the acquisition of clinical-stage biotechnology firm, Versantis, for $109m (Sfr105m).

Pascal prigentTablet press manufacture for compaction simulationPriority review voucherPowdered cleaning detergentsPress manufactureCompaction simulationPreference management solution

FDA, NIH partner for neurodegenerative disease treatment development

The US FDA and NIH have unveiled a public-private partnership (PPP) to understand and develop treatments for neurodegenerative diseases.

Hilary marstonJoe bidenCritical path instituteTablet press manufacture for compaction simulationHealthcare companiesHuman servicesUs department of healthDrug administrationUs national institutes of healthCritical pathRare neurodegenerative diseasesRare disease cures accelerator dataAnalytics platformAccelerating accessCritical therapiesPress manufacture

North America is seeing a hiring boom in pharmaceutical industry machine learning roles

The number of roles in North America made up 63.9% of total machine learning jobs.

United statesTablet press manufacture for compaction simulationCold chain solutionsNorth americaSouth san franciscoPress manufactureCompaction simulationLow temperature refrigerationCold chainSeparation solutionsPurifying active pharmaceutical

California s low-cost insulin plans receive $100m manufacturing boost

Governor Newsom unveils plans to work with a CMO to produce low-cost insulin, as most big pharma insulin is currently produced in-house.

United kingdomUnited statesGavin newsomSanofi lantusEli lilly humalogNovo nordisk novologNewsom calrx biosimilarEli lillyAllan coukellCalifornia department of health care accessDiabetes research foundationTablet press manufacture for compaction simulationAmphastar pharmaceuticalsMannkind corp afrezzaUs senate finance committeeNovo nordisk

HDT Bio receives Emergency Use Approval for Covid-19 vaccine in India

HDT Bio has received Emergency Use Approval from the Indian regulators for its Covid-19 vaccine, Gemcovac.

South koreaGemcovac covidSteve reedTablet press manufacture for compaction simulationAnalytical services for biological assaysEmergency use approvalGennova biopharmaceuticalsPress manufactureCompaction simulationPeptide synthesisPeptide libraries

vimarsana © 2020. All Rights Reserved.